Area of research
Dermatology · Immunology and Allergy
Research interest
Research interests include Medicine, Atopic dermatitis, Dermatology, Guideline, Family medicine, and Task force.
European Guideline (<scp>EuroGuiDerm</scp>) on atopic eczema: Living update
Vitiligo – a disease: A position paper on stigmatization, life quality impairment and psychosocial comorbidity
EADV Task Force Pruritus White Paper on chronic pruritus and chronic prurigo: Current challenges and future solutions
Italian S3-Guideline on the treatment of Atopic Eczema - Part 1: Systemic therapy, adapted from EuroGuiDerm by the Italian Society of Dermatology and STD (SIDEMAST), the Italian Association of Hospital Dermatologists (ADOI) and the Italian Society of Allergological and Environmental Dermatology (SIDAPA)
Stress Affects Mast Cell Proteases in Murine Skin in a Model of Atopic Dermatitis-like Allergic Inflammation
Krankheit Vitiligo – Ein Positionspapier zur Stigmatisierung, Einschränkung der Lebensqualität und psychosozialen Komorbidität
Italian S3-Guideline on the treatment of Atopic Eczema - Part 2: non-systemic treatments and treatment recommendations for special AE patient populations, adapted from EuroGuiDerm by the Italian Society of Dermatology and STD (SIDEMAST), the Italian Association of Hospital Dermatologists (ADOI) and the Italian Society of Allergological and Occupational Dermatology (SIDAPA)
Italian S3-Guideline on the treatment of Atopic Eczema - First Update, adapted from EuroGuiDerm by the Italian Society of Dermatology and STD (SIDEMAST), the Italian Association of Hospital Dermatologists (ADOI) and the Italian Society of Allergological and Occupational Dermatology (SIDAPA)
First update of the living European guideline (<scp>EuroGuiDerm</scp>) on atopic eczema
European guideline (EuroGuiDerm) on atopic eczema: part I – systemic therapy
European guideline (<scp>EuroGuiDerm</scp>) on atopic eczema – part <scp>II</scp>: non‐systemic treatments and treatment recommendations for special <scp>AE</scp> patient populations
European Task Force on Atopic Dermatitis: position on vaccination of adult patients with atopic dermatitis against COVID‐19 (SARS‐CoV‐2) being treated with systemic medication and biologics
Risk of severe allergic reactions to COVID‐19 vaccines among patients with allergic skin diseases – practical recommendations. A position statement of ETFAD with external experts
ETFAD/EADV Eczema task force 2020 position paper on diagnosis and treatment of atopic dermatitis in adults and children
European Task Force on Atopic Dermatitis statement on severe acute respiratory syndrome coronavirus 2 (SARS‐Cov‐2) infection and atopic dermatitis
European Task Force on Atopic Dermatitis (ETFAD): treatment targets and treatable traits in atopic dermatitis
European S2k Guideline on Chronic Pruritus
European task force on atopic dermatitis position paper: treatment of parental atopic dermatitis during preconception, pregnancy and lactation period
Lichen planus: a comprehensive evidence‐based analysis of medical treatment
Consensus‐based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: part I
Consensus‐based European guidelines for treatment of atopic eczema (atopic dermatitis) in adults and children: part II
Experiences with the first eczema school in the United States
Effects of structured patient education in adults with atopic dermatitis: Multicenter randomized controlled trial
Treatment Adherence Intervention Studies in Dermatology and Guidance on How to Support Adherence
Brain Processing of Contagious Itch in Patients with Atopic Dermatitis
New aspects in allergy education with special emphasis on anaphylaxis
S2k guideline on diagnosis and treatment of atopic dermatitis — short version
Global Allergy Forum and 3rd Davos Declaration 2015